Back
Ready Capital 10K Form
Buy
56
RC
Ready Capital
Last Price:
7.08
Seasonality Move:
-1.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-08 | 10Q | RC/Ready Capital Quarterly |
2023-08-08 | 10Q | RC/Ready Capital Quarterly |
2023-05-09 | 10Q | RC/Ready Capital Quarterly |
2022-11-08 | 10Q | RC/Ready Capital Quarterly |
2022-08-05 | 10Q | RC/Ready Capital Quarterly |
2022-05-06 | 10Q | RC/Ready Capital Quarterly |
Receive RC News And Ratings
See the #1 stock for the next 7 days that we like better than RC
RC Financial Statistics
Sales & Book Value
Annual Sales: | $389.94M |
---|---|
Cash Flow: | $1.06M |
Price / Cash Flow: | 0 |
Annual Sales: | $12.59 |
Price / Book: | 0.57 |
Profitability
EPS (TTM): | -0.70000 |
---|---|
Net Income (TTM): | $-109.85M |
Gross Margin: | $61.3M |
Return on Equity: | -4.38% |
Return on Assets: | -0.91% |
Ready Capital Earnings Forecast
Key Ready Capital Financial Ratios
- The Gross Profit Margin over the past 14 years for RC is 42.66%.
- The Selling, General & Administrative Expenses for RC have been equal to 23.97% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 184.34% of Operating Income.
- The Net Earning history of RC is 87.05% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 13 years.
Ready Capital Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Mortgage Real Estate Investment Trusts (REITs) |
Sector: | Financials |
Current Symbol: | RC |
CUSIP: | 75574U |
Website: | readycapital.com |
Debt
Debt-to-Equity Ratio: | 3.67 |
---|---|
Current Ratio: | 0.59 |
Quick Ratio: | 0.56 |
Price-to-Earnings
Trailing P/E Ratio: | 3.24 |
---|---|
Forward P/E Ratio: | 6.21 |
RC Technical Analysis vs Fundamental Analysis
Buy
56
Ready Capital (RC)
is a Buy
Is Ready Capital a Buy or a Sell?
-
Ready Capital stock is rated a Buy
The current Ready Capital [RC] share price is $7.11. The Score for RC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.